Daniel A. Jepson

Suggest Changes
Learn More
598 Background: Anthracyclines and taxanes are now standard of care for LABC. Phase III trials have demonstrated pathological complete responses of the breast (pCR) of 20-34% in studies of primary(More)
  • 1